Belgium's Walloon Region Funds $2.2M to Explore Role of DNA Hydroxymethylation in Breast Cancer | GenomeWeb

NEW YORK (GenomeWeb) – Belgium's Walloon Region has earmarked about €1.6 million ($2.2 million) to a project aimed at exploring the role DNA hydroxymethylation may play in breast cancer, the Université Libre de Bruxelles announced today.

The aim of the CANDx project is to develop new diagnostic and therapeutic tools for aggressive breast cancer tumors. François Fuks, head of ULB's Laboratory of Cancer Epigenetics, is coordinating the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.